AA
AlphaMark Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q4 | – | Sell |
-9,310
| Closed | -$796K | – | 481 |
|
2018
Q3 | $796K | Sell |
9,310
-1,805
| -16% | -$154K | 0.32% | 65 |
|
2018
Q2 | $1.29M | Sell |
11,115
-3,600
| -24% | -$417K | 0.52% | 48 |
|
2018
Q1 | $1.19M | Sell |
14,715
-5,235
| -26% | -$424K | 0.51% | 44 |
|
2017
Q4 | $1.17M | Sell |
19,950
-5,550
| -22% | -$326K | 0.46% | 45 |
|
2017
Q3 | $1.19M | Sell |
25,500
-7,500
| -23% | -$351K | 0.51% | 44 |
|
2017
Q2 | $1.19M | Hold |
33,000
| – | – | 0.51% | 46 |
|
2017
Q1 | $1.02M | Hold |
33,000
| – | – | 0.47% | 49 |
|
2016
Q4 | $1.11M | Hold |
33,000
| – | – | 0.57% | 45 |
|
2016
Q3 | $878K | Buy |
+33,000
| New | +$878K | 0.44% | 57 |
|